Unstructured Finance

from Global Markets Forum Dashboard:

GMF @HedgeWorld West, World Bank/IMF and Financial & Risk Summit Toronto 2014

October 3, 2014

(Updates with guest photos and new links).

Join our special coverage Oct. 6-10 in the Global Markets Forum as we hit the road, from the West Coast to Washington to the Great White North.

Wall Street’s trading businesses turn to survival of the least dead

May 4, 2013

Darwin theorized that peacocks’ colorful plumage was a sign of        their evolutionary strength.

Goldman: 1, Volcker: 0

January 8, 2013

By Lauren Tara LaCapra

There’s an interesting article out today from Bloomberg, which accuses Goldman Sachs of skirting the yet-to-be-defined-or-implemented Volcker rule, and accuses its top executives, including CEO, Lloyd Blankfein, of being a hypocrite.

PIMCO and BlackRock go strolling down K Street

By Jennifer Ablan
February 29, 2012

By Jennifer Ablan and Matthew Goldstein

Wall Street may hate financial regulatory reform, but lobbyists certainly love it—especially ones working on behalf of giant asset managers PIMCO and BlackRock, which control a total of nearly $5 trillion in assets.

Hedge funds against Obama

By Jennifer Ablan
December 19, 2011

By Jennifer Ablan and Matthew Goldstein

Class warfare has been the topic du jour this year and is likely to be a major theme of the 2012 election. In a speech two weeks ago, President Barack Obama blasted his Republican foes and Wall Street as he portrayed himself as a champion of the middle class.

LIPPER: Are ETFs in trouble?

December 15, 2011

By Detlef Glow,  Head of EMEA Research at Thomson Reuters fund research firm Lipper. The views expressed are his own.

MF Global a month later and still a mystery

November 27, 2011

By Matthew Goldstein

It’s been about a month since MF Global began spiraling towards bankruptcy and still there’s no clarity about what happened to the missing customer money that was supposed to be kept in untouchable, segregated accounts. It’s not even clear how much money is missing.

Deals wrap: Waiting for a hostile bid

June 10, 2011

The head of TMX Group said on Friday a hostile bid could come “any day now,” as a consortium of banks and pension funds prepares to take their approximately $3.7 billion offer for the Canadian exchange operator straight to its shareholders.

Lipper: Fighting fragmentation

March 17, 2011

By Merieme Boutayeb, Research Analyst at Lipper. The views expressed are her own.

Deals wrap: Key facts about the Sanofi/Genzyme deal

February 16, 2011

Chris Viehbacher, CEO of Sanofi-Aventis, gestures as he speaks during a news conference to present Sanofi-Aventis' 2010 annual results in Paris February 9, 2011.   REUTERS/Charles Platiau  French drugmaker Sanofi-Aventis agreed to buy Genzyme with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group’s drugs, the companies said. Reuters has a factbox about the two companies, a timeline of Sanofi’s quest for Genzyme and a look at Sanofi’s patient CEO.